Alerts will be sent to your verified email
Verify EmailINFINIUM
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Infinium Pharmachem Limited, founded in 2003, specializes in Iodine chemistry, providing high-quality Iodine Derivatives & APIs. They offer full services from R&D to commercial production for pharmaceutical, agrochemical, and related industries.
Infinium Pharmachem major competitors are Titan Bio-Tech, Kanoria Chem. & Inds, Lords Chloro Alkali, Nikhil Adhesives, Diamines & Chemicals, Alufluoride, National Peroxide.
Market Cap of Infinium Pharmachem is ₹446 Crs.
While the median market cap of its peers are ₹394 Crs.
Infinium Pharmachem seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
Earnings Release | ||||||||||||||||||
Investor Presentation | Mar | Sep | ||||||||||||||||
Conference Call | Mar | Mar | ||||||||||||||||
Conference Call SummaryCon Call Summary
Powered by Gemini
|